A Prospective, Double-Blind, Randomized, Placebo-Controlled, Crossover Study Using an Orally Administered Oxalate Decarboxylase (OxDC)
一项前瞻性、双盲、随机、安慰剂对照、交叉研究，采用口服草酸脱羧酶（OxDC）
期刊:Kidney360
影响因子:3
doi:10.34067/KID.0001522020
Quintero, Emily; Bird, Victoria Yvonne; Liu, Howard; Stevens, Gary; Ryan, Alan S; Buzzerd, Sabrina; Klimberg, Ira W
